PTGDS and esophageal squamous cell carcinoma: Analyzing PTGDS expression in ESCC cohorts treated with anti-PD-1/PD-L1 agents or neoadjuvant chemoradiation retrospectively could help determine if PTGDS-low status predicts resistance to treatment.